Business · 08/04/2004Updated: 10/17/2026 · 1 min read
FDA Hosts Public Workshop on Using Radiolabeled Platelets to Evaluate Platelet Product Viability
Summary
The US Food and Drug Administration (FDA) is hosting a public workshop to discuss the use of radiolabeled platelets as a method for assessing the viability of platelet products in living organisms.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →